References
- Roche experimenting with new pricing models in oncology. The Pink Sheet 10 June 2013. Available from: http://altaica1.tumblr.com/post/53017371649/roche-experimenting-with-new-pricing-models-in .
- Bach P. Indication-specific pricing for cancer drugs. JAMA. 2014; 312(16): 1629–30.
- Kitamura M, Koch J. Bloomberg 2016, November 16. Available from: http://www.bloomberg.com/news/articles/2015-11-16/express-scripts-to-apply-new-price-model-to-auto-immune-diseases .
- Anno Fricke. AMNOG soll auf Prüfstand. Ärzte Zeitung; 2016. Available from: http://www.aerztezeitung.de/politik_gesellschaft/arzneimittelpolitik/default.aspx?sid=902850&cm_mmc=Newsletter-_-Newsletter-C-_-20160119-_-Arzneimittelpolitik [cited 18 January 2016]..
- German Social Code. Book Five (SGB V), Section 35a. Available from: http://www.gesetze-im-internet.de/bundesrecht/sgb_5/gesamt.pdf [cited 17 February 2016]..
- German Social Code. Book Five (SGB V), Section 35a English summary. Available from: http://www.english.g-ba.de/benefitassessment/information/ [cited 1 May 2016]..
- Transparency Commission Task. Available from: http://www.has-sante.fr/portail/jcms/c_412210/en/commission-de-la-transparence [cited 18 November 2015]..
- Transparency Commission Task English Summary. Available from: http://www.has-sante.fr/portail/jcms/c_1729421/en/transparency-committee [cited 29 October 2015]..
- HAS. Information on Proper use contracts. Available from: http://www.has-sante.fr/portail/jcms/r_1500923/fr/syntheses-d-avis-et-fiches-bon-usage-sur-les-medicaments [cited 2 April 2013]..
- Code de Santé Publique. Article R5132-3. Available from: https://www.legifrance.gouv.fr/affichCodeArticle.do?cidTexte=LEGITEXT000006072665&idArticle=LEGIARTI000006915531&dateTexte=&categorieLien=cid [cited 23 December 2013]..
- NSM. Decision on Avastin temporary usage recommendation. Available from: http://ansm.sante.fr/Dossiers/Referentiels-de-bon-usage-des-medicaments/Referentiels-de-bon-usage-des-medicaments/(offset)/0 [cited 25 June 2015]..
- AIFA Updated list of Records and Therapeutic web based Plans. Available from: http://www.agenziafarmaco.gov.it/it/content/lista-aggiornata-dei-registri-e-dei-piani-terapeutici-web-based [cited April 2016]..
- AIFA CTS. Decision 366. Available from: http://www.agenziafarmaco.gov.it/it/content/avastin-nella-lista-dei-farmaci-di-uso-consolidato-la-degenerazione-maculare-senile [cited 10 June 2014]..
- AIFA Pricing and Reimbursement. Available from: http://www.agenziafarmaco.gov.it/en/content/pricing-and-reimbursement [cited November 2015]..
- Esposito L, Paganelli F. Improving the quality of data in the Onco-AIFA register as a prerequisite for outcome research studies. Eur J Hosp Pharm. 2012; 19: 244.
- Navarria A, Drago V, Gozzo L, Longo L, Mansueto S, Pignataro G, etal. Do the current performance-based schemes in Italy really work? “Success Fee”: A novel measure for cost-containment of drug expenditure. Value Health. 2015; 18: 131–6.
- Spanish Official Bulletin, 25 July 2015. Available from: https://www.boe.es/boe/dias/2015/07/25/pdfs/BOE-A-2015-8343.pdf .
- Interoperability of electronic prescriptions and advances in 12 regions. Available from: http://www.diariofarma.com/2015/08/25/la-interoperabilidad-de-la-recta-electronica-avanza-ya-en-12-comunidades [cited 25 August 2015]..
- Brizuela L. Estudio de implantación de receta electrónica en España. Farmacéuticos Comunitarios. 2014; 6(Suplemento1). Available from: http://www.farmaceuticoscomunitarios.org/journal-article/estudio-implantacion-receta-electronica-espana [cited 30 April 2016]..
- National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence. 2008
- The Pharmaceutical Price Regulation Scheme 2014. Department of Health. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/282523/Pharmaceutical_Price_Regulation.pdf [cited December 2013]..
- National Cancer Drugs Fund List. Available from: https://www.england.nhs.uk/wp-content/uploads/2015/09/ncdf-list-sept15.pdf [cited 11 Septembre 2015]..
- National Cancer Intelligence Network. Available from: http://www.chemodataset.nhs.uk/home [cited 1 May 2016]..
- NHS RightCare. Available from: http://www.rightcare.nhs.uk/ [cited 1 May 2016]..
- The Swedish Pharmaceutical Reimbursement System . English summary. Available from: http://www.tlv.se/Upload/English/ENG-swe-pharma-reimbursement-system.pdf [cited January 2007]..
- Tandvårds- och läkemedelsförmånsverket (TLV). Types of reimbursement. Available from: http://www.tlv.se/In-English/medicines-new/pricing-and-reimbursement-of-medicines/types-of-reimbursement/ [cited 23 November 2015]..
- National Pharmaceutical StrategyAction Plan 2014. Available from: http://www.government.se/contentassets/57e68c08f2f04e0490fb5638aac230f1/national-pharmaceutical-strategy—action-plan-2014 [cited March 2014]..
- Tandvårds- och läkemedelsförmånsverket (TLV) Mission statement. Available from: http://www.tlv.se/lakemedel/Utvecklingvardebaserad-prissattning/ [cited 1 May 2016].